Eosinophils are important components of the immune system, and are often involved in hypersensitivity disorders and parasitic infestation.1 Eosinophilia is defined as an increase in the total eosinophil count in blood or tissue. Although the upper reference range for blood concentration of eosinophils in dogs is 0.75 x 109/L, significant circulating eosinophilia is considered to be present when the count exceeds 2.2-2.5 x 109/L.2 This most commonly occurs as a leukaemoid response, or when eosinophil counts increase to a high levels in response to an underlying cause (see Table).2 The most common underlying causes for an eosinophilic leukaemoid response in people are atopy and helminth infestation.1 Dogs with Angiostrongylus vasorum (lungworm) or Dirofilaria immitis (heartworm) have been shown to have significant eosinophilia in a significant percentage of infected dogs.2,3 However, in one survey performed by our centre of Perth metropolitan Rottweiler breeding kennels, it does not appear that the presence of low numbers of intestinal parasites predispose to higher eosinophil counts. A few dogs had intestinal parasites present (one or more of Trichuris, Isospora, Giardia and Sarcocystis), but none were considered clinically affected.
Common Causes
Dogs are most commonly identified with eosinophilia secondary to dermatological diseases (such as sarcoptic mange), inflammatory bowel disease and pulmonary diseases, all of which may have a hypersensitivity component.4-7 Interestingly, atopic dermatitis does not seem to cause a significant eosinophilia in dogs.6,8 Paraneoplastic eosinophilia is commonly reported, as is eosinophilic CNS disease.2,6,9-12 Dogs may also have significant organ infiltration with eosinophils (such as with eosinophilic bronchopneumopathy), but no circulating eosinophilia.5 This may be due to the short circulating half-life of these cells.7 Diurnal variation may also play a role, as circulating eosinophil numbers in healthy dogs have been shown to peak in late evening, and be at their lowest at noon.13
Breed Prevalence
In both our local survey and in a large published analysis of eosinophilia, Rottweilers have been shown to be predisposed to eosinophilic disease.6 A number of the Rottweilers that we surveyed had increased eosinophilic counts, but no identifiable parasitic, allergic or neoplastic disease, and there was no age or sex predisposition. However, certain kennels did seem to have increased incidence of eosinophilia, suggesting there may be a heritable component. German shepherds also appear to have an increased incidence of exaggerated eosinophil responses to normal stimuli.6 Cavalier King Charles spaniels, Alaskan malamutes and Siberian huskies appear predisposed to eosinophilic stomatitis, intestinal and airway disease.5,14-16
Rottweilers are also over-represented in the published reports of hypereosinophilic syndrome (HES).2,17 HES is a rare syndrome that has been described in people, cats and less commonly in dogs.1,2,17-19 The criteria for the definition of idiopathic HES used in people are an eosinophil count persistently greater than 1.5x109/L, damage to end-organs such as the heart and lungs, no ascertainable cause for the eosinophilia and no evidence of clonality.1 The prognosis for this condition is considered universally poor. However, there have been individual reports of good survival times with spontaneous resolution reported in one dog and resolution with hydroxyurea and prednisolone treatment in another.17, 18 Recently we have seen two related dogs (Rottweilers) that fulfilled the criteria for HES, but recovered with no, or very short-term, treatment. This suggests that there may be a similar disease to the 'benign HES' identified in people. Differentiation of HES from eosinophilic leukaemia (EL) is difficult, but generally demonstration of >5% blast cells in the bone marrow is necessary for diagnosis of EL.1
Mechanism
The exact mechanisms for eosinophilic production are unknown, but interleukin-5 (IL-5), IL-3 and GM-CSF all inhibit eosinophil apoptosis and have specific receptors on eosinophils and basophils.1,2 Production of IL-5 by neoplastic lymphocytes has been implicated as one potential cause of paraneoplastic eosinophilia. Basophils are also primed by IL-3 and therefore basophilia often accompanies eosinophilia.2 Eosinophilic bronchopneumopathy has been identified as being mediated by CD4+ lymphocytes with a concurrent decrease in CD8+ lymphocytes, suggesting a T helper (Th)-2 mediated response.5 Further investigations of the molecular signaling mechanisms in affected animals is warranted, as this may allow for establishing simple tests to allow differentiation between allergic, infiltrative eosinophilic and neoplastic disease in dogs of all breeds.
Whatever the mechanism of initial production by the bone marrow, eosinophils are then attracted into tissues by local chemo-attractant molecules.1 This is generally a Th-2 mediated response, and may be appropriate in cases of parasitism, as the cytotoxic components of eosinophils may destroy the parasite. Eosinophils contain many toxic inflammatory mediators.1 Eosinophil cationic protein in particular appears to promote the activity of other toxic mediators in target tissue.20 In addition, eosinophils produce compounds capable of increasing vascular permeability, stimulating mucus secretion and smooth muscle contraction.17 If eosinophilia is inappropriately stimulated (i.e., in the absence of helminths), the accumulation of eosinophils has the potential to cause significant damage to the target organs.
Table. Potential causes of eosinophilia in dogs.
Parasitic:
Ancylostomiasis
Dirofilariasis
Dipetalonemiasis
Ctenophalidiasis
Angiostrongylosis
Ascariasis
Paragonimiasis
Sarcoptes scabiei
Pneumomonyssoides caninum (?)
Hypersensitivity:
Flea allergy dermatitis
Food allergy
Eosinophilic infiltrative disorders:
Eosinophilic bronchopneumopathy
Eosinophilic gastroenteritis/colitis
Hypereosinophilic syndrome
Infectious diseases:
Suppurative processes (chronic upper respiratory disease, pneumonia, metritis, mastitis, lower urinary tract infection)
Neoplasia:
Mast cell tumour
Lymphomas
Myeloproliferative disorders
Solid tumours (myxosarcoma, basal cell tumour, squamous cell carcinoma, salivary gland adenocarcinoma, sweat gland adenocarcinoma)
Haemangiosarcoma
Miscellaneous:
Soft tissue trauma
Cardiomyopathy
Renal failure (?)
Oestrus (?)
Acute gastroenteritis (?)
Pemphigus foliaceous (?)
Snakebite (?)
Hypoadrenocorticism (?)
Immune mediated haemolytic anaemia (?)
Hepatopathy (?)
Chronic renal failure (?)
Arthrosis (?)
Hypocalcaemia (?)
Pulmonary oedema (?)
Constipation (?)
Diabetes mellitus (?)
Hypoparathyroidism (?)
Juvenile nephropathy (?)
Hydrothorax (?)
Panosteitis (?)
References
1. Rothenberg. NEJM 1998 338:1592-1600
2. Lilliehook, Tvedten. VCNA (SA Practice) 2003 33:1359-1378
3. Willesen, et al. Vet J 2007 Epub
4. Guilford In: Strombeck's Small Animal Gastroenterology. 3rd edn. 1996:451-456.
5. Clercx, et al. JVIM 2000 14:282-291
6. Lilliehook, et al. JSAP 2000 41:248-253
7. Corcoran, et al. JSAP 1991 494-502
8. Hayshiya, et al. J Vet Med A Physiol Path Clin Med 2002 49:27-31
9. Ozaki, et al. Vet Path 2006 43:339-344
10. Marchetti, et al. Vet Clin Path 2005 34:259-263
11. Salvadori, et al. JSAP 2007 48:466-499
12. Bennett, et al. Aust Vet J 1997 75:786-789
13. Lilliehook. Vet Clin Path 1997 26:113-117
14. Rajamaki, et al. Vet J 2002 163:168-181
15. German, et al. JSAP 2002 43: 533-538
16. Calvert, et al. JAAAHA 1988 311-320
17. Sykes, et al. JVIM 2001 15:162-166
18. Perkins, Watson. Aust Vet J 2001 79:686-689
19. Aroch, et al. Vet Rec 2001 149:386-389
20. Young, et al. Nature 1986 321:612-616